Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
X4 Pharmaceuticals Inc (DE:48Q)
FRANKFURT:48Q
RESEARCH TOOLSreports
X4 Pharmaceuticals (48Q) Stock Price & Analysis
1 Followers
48Q Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.56 - €2.30
Previous Close€1.26
Volume0.00
Average Volume (3M)16.17K
Market Cap
€192.86M
Enterprise Value€89.26M
Total Cash (Recent Filing)$114.22M
Total Debt (Recent Filing)$3.71M
Price to Earnings (P/E)N/A
Beta1.57
Next Earnings
May 09, 2024EPS Estimate
-€0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding167,937,781
10 Day Avg. Volume240
30 Day Avg. Volume16,166
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)6.77
Price to Sales (P/S)3958.53
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue457.74
Enterprise Value/Gross Profit457.74
Enterprise Value/Ebitda-5.20
Forecast
1Y Price Target
€2.80Price Target Upside122.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
X4 Pharmaceuticals News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors
48Q FAQ
What was X4 Pharmaceuticals Inc’s price range in the past 12 months?
X4 Pharmaceuticals Inc lowest stock price was €0.56 and its highest was €2.30 in the past 12 months.
What is X4 Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is X4 Pharmaceuticals Inc’s upcoming earnings report date?
X4 Pharmaceuticals Inc’s upcoming earnings report date is May 09, 2024 which is in 14 days.
How were X4 Pharmaceuticals Inc’s earnings last quarter?
X4 Pharmaceuticals Inc released its earnings results on Mar 21, 2024. The company reported -€0.094 earnings per share for the quarter, beating the consensus estimate of -€0.137 by €0.043.
Is X4 Pharmaceuticals Inc overvalued?
According to Wall Street analysts X4 Pharmaceuticals Inc’s price is currently Undervalued.
Does X4 Pharmaceuticals Inc pay dividends?
X4 Pharmaceuticals Inc does not currently pay dividends.
What is X4 Pharmaceuticals Inc’s EPS estimate?
X4 Pharmaceuticals Inc’s EPS estimate is -€0.14.
How many shares outstanding does X4 Pharmaceuticals Inc have?
Currently, no data Available
What happened to X4 Pharmaceuticals Inc’s price movement after its last earnings report?
X4 Pharmaceuticals Inc reported an EPS of -€0.094 in its last earnings report, beating expectations of -€0.137. Following the earnings report the stock price went up 4.571%.
Which hedge fund is a major shareholder of X4 Pharmaceuticals Inc?
Among the largest hedge funds holding X4 Pharmaceuticals Inc’s share is Perceptive Advisors LLC. It holds X4 Pharmaceuticals Inc’s shares valued at 3M.
---
X4 Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€2.80 (122.83% Upside)
€2.80 (122.83% Upside)
Blogger Sentiment
Bullish
DE:48Q Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.17%
12-Months-Change
Fundamentals
Return on Equity
-161.67%
Trailing 12-Months
Asset Growth
-5.35%
Trailing 12-Months
Company Description
X4 Pharmaceuticals Inc
X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.
---
48Q Earnings Call
Q4 2024
0:00 / 0:00
---
48Q Stock 12 Months Forecast
Average Price Target
€2.80
▲(122.83% Upside)
Technical Analysis
Best Analysts Covering 48Q
1 Year
1 Year Success Rate
6/15 ratings generated profit
1 Year Average Return
-9.89%
reiterated a buy rating 4 months ago
Copying Leland Gershell's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -9.89% per trade.
---